Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Basal Cell 3 Pancreatic Neoplasms 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Telangiectasis 1 Skin Neoplasms 1 Rosacea 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Port-Wine Stain 1 Pancreatic Intraductal Neoplasms 1 Non-melanoma Skin Cancer 1 Nevus, Pigmented 1 Nasopharyngeal Neoplasms 1 Mixed Tumor, Malignant 1 Melanoma 1 Lung Neoplasms 1 Keratosis, Seborrheic 1 Keratosis 1 Hemangioma 1 Glioma 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Barrett Esophagus 1

Interventions

Docetaxel 277 Prednisone 236 enzalutamide 175 Leuprolide 172 Radiotherapy 164 Abiraterone Acetate 153 Magnetic Resonance Spectroscopy 147 bicalutamide 137 Goserelin 134 Androgen Antagonists 111 Radiosurgery 101 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100 apalutamide 78 abiraterone 75 gallium 68 PSMA-11 74 Specimen Handling 67 Gonadotropin-Releasing Hormone 58 darolutamide 56 Radiation 56 Triptorelin Pamoate 53 cabazitaxel 49 Zoledronic Acid 49 pembrolizumab 48 Radiotherapy, Intensity-Modulated 47 Flutamide 47 Brachytherapy 47 luprolide acetate gel depot 46 Standard of Care 45 Carboplatin 44 Estramustine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × Tomography, Optical Coherence × Clear all

NCT03253458 2019-01-18

FPI

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡